Organic compounds -- part of the class 532-570 series – Organic compounds – Carboxylic acids and salts thereof
Reexamination Certificate
2005-05-03
2011-11-08
Zucker, Paul A (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carboxylic acids and salts thereof
C514S569000
Reexamination Certificate
active
08053598
ABSTRACT:
Novel compounds of the general formula (I), the use of these compounds as pharmaceutical compositions, pharmaceutical compositions comprising the compounds and methods of treatment employing these compounds and compositions. The present compounds may be useful in the treatment and/or prevention of conditions mediated by Peroxisome Proliferator-Activated Receptors (PPAR), in particular the PPARδ subtype.
REFERENCES:
patent: 4148915 (1979-04-01), Thuillier et al.
patent: 4920132 (1990-04-01), Huang et al.
patent: 5324743 (1994-06-01), Dillard et al.
patent: 5773469 (1998-06-01), Kanojia et al.
patent: 5919793 (1999-07-01), Brown et al.
patent: 6448293 (2002-09-01), Andrews et al.
patent: 6525094 (2003-02-01), Zhang et al.
patent: 6555577 (2003-04-01), Mogensen et al.
patent: 6569901 (2003-05-01), Mogensen et al.
patent: 6630504 (2003-10-01), Andrews et al.
patent: 6867218 (2005-03-01), Mogensen et al.
patent: 6869967 (2005-03-01), Jeppesen et al.
patent: 6869975 (2005-03-01), Abe et al.
patent: 6875780 (2005-04-01), Auerbach et al.
patent: 6972294 (2005-12-01), Murray et al.
patent: 7091245 (2006-08-01), Jeppesen et al.
patent: 7129268 (2006-10-01), Jeppesen et al.
patent: 7202213 (2007-04-01), Mogensen et al.
patent: 7709528 (2010-05-01), Jeppesen et al.
patent: 7943612 (2011-05-01), Sauerberg
patent: 7943613 (2011-05-01), Sauerberg et al.
patent: 2002/0115654 (2002-08-01), Jeppesen et al.
patent: 2004/0024034 (2004-02-01), Brooks et al.
patent: 2005/0080115 (2005-04-01), Jeppesen et al.
patent: 2008/0114036 (2008-05-01), Havranek et al.
patent: 2010/0197950 (2010-08-01), Rasmussen et al.
patent: 2010/0210653 (2010-08-01), Havranek et al.
patent: 2011/0039841 (2011-02-01), Polivka et al.
patent: 2003-171275 (2003-06-01), None
patent: 97/27847 (1997-08-01), None
patent: 97/27857 (1997-08-01), None
patent: 97/28115 (1997-08-01), None
patent: 97/28137 (1997-08-01), None
patent: 97/28149 (1997-08-01), None
patent: WO 97/43241 (1997-11-01), None
patent: WO 97/48674 (1997-12-01), None
patent: 98/27974 (1998-07-01), None
patent: 99/04815 (1999-02-01), None
patent: WO 99/20275 (1999-04-01), None
patent: WO 00/63153 (2000-10-01), None
patent: 01/00603 (2001-01-01), None
patent: 01/25181 (2001-04-01), None
patent: WO 01/25226 (2001-04-01), None
patent: WO 01/34137 (2001-05-01), None
patent: WO 01/34200 (2001-05-01), None
patent: WO 01/55085 (2001-08-01), None
patent: WO 01/55086 (2001-08-01), None
patent: WO 01/60807 (2001-08-01), None
patent: WO 01/66098 (2001-09-01), None
patent: 01/79197 (2001-10-01), None
patent: 02/14291 (2002-02-01), None
patent: WO 02/28434 (2002-04-01), None
patent: 02/46154 (2002-06-01), None
patent: WO 02/50048 (2002-06-01), None
patent: WO 2002/053547 (2002-07-01), None
patent: 02/059098 (2002-08-01), None
patent: WO 2002/062774 (2002-08-01), None
patent: WO 2002/070011 (2002-09-01), None
patent: 02/076957 (2002-10-01), None
patent: 02/079162 (2002-10-01), None
patent: 02/080899 (2002-10-01), None
patent: 02/098840 (2002-12-01), None
patent: 02/100812 (2002-12-01), None
patent: WO 2003/002081 (2003-01-01), None
patent: 03/016265 (2003-02-01), None
patent: 03/016291 (2003-02-01), None
patent: WO 2003/011807 (2003-02-01), None
patent: WO 2003/011814 (2003-02-01), None
patent: WO 2003/02395 (2003-03-01), None
patent: 03/033493 (2003-04-01), None
patent: 03/035603 (2003-05-01), None
patent: 03/072100 (2003-09-01), None
patent: 03/074050 (2003-09-01), None
patent: 03/074051 (2003-09-01), None
patent: 03/074052 (2003-09-01), None
patent: WO 2003/074495 (2003-09-01), None
patent: 03/084916 (2003-10-01), None
patent: 03/097607 (2003-11-01), None
patent: WO 2004/000315 (2003-12-01), None
patent: WO 2004/000762 (2003-12-01), None
patent: 2004/005253 (2004-01-01), None
patent: WO 2004/007439 (2004-01-01), None
patent: 2004/022533 (2004-03-01), None
patent: WO 2004/037775 (2004-05-01), None
patent: WO 2004/037776 (2004-05-01), None
patent: WO 2004/060871 (2004-07-01), None
patent: WO 2004/063165 (2004-07-01), None
patent: WO 2004/063166 (2004-07-01), None
patent: WO 2004/073606 (2004-09-01), None
patent: WO 2004/080943 (2004-09-01), None
patent: WO 2004/080947 (2004-09-01), None
patent: WO 2004/092117 (2004-10-01), None
patent: WO 2004/093879 (2004-11-01), None
patent: WO 2004/099170 (2004-11-01), None
patent: WO 2005/054176 (2005-06-01), None
patent: WO 2005/097098 (2005-10-01), None
patent: WO 2005/097762 (2005-10-01), None
patent: WO 2005/097763 (2005-10-01), None
patent: WO 2005/105725 (2005-11-01), None
patent: WO 2005/105735 (2005-11-01), None
patent: WO 2007/071766 (2007-06-01), None
patent: WO 2007/101864 (2007-09-01), None
patent: WO 2007/141295 (2007-12-01), None
Berger, J et al—The J of Biological Chem—1999—vol. 274—Part 10—pp. 6718-6725.
Leibowitz, M.D. et al—F E B S Lett—2000—vol. 473—pp. 333-336.
Oliver, W.R. et al—PNAS—2001—vol. 98—Part 9—pp. 5306-5311.
Muoio, D.M. et al—The J of Biological Chem—2002—vol. 277—Part 29—pp. 26089-26097.
Wang, Y-X et al—Cell—2003—vol. 113—pp. 159-170.
Luquet, S et al—FASEB J—2003—vol. 17—Part 13—pp. 209-226.
Tanaka, T et al—PNAS—2003—vol. 100—Part 26—pp. 15924-15929.
Holst, D et al—Biochem Biophys Acta—2003—vol. 1633—pp. 43-50.
Dressel, U et al—Mol Endocrinol—2003—vol. 17—Part 12—pp. 2477-2493.
Lee, C-H et al—Science—2003—vol. 32—pp. 453-457.
Berger et al., “Physiological and Therapeutic Roles of Peroxisome Proliferator-Activated Receptors,”, Diabetes Technology & Therapeutics, 4(2);163-174 (2002).
Chilonczyk et al., “Hypolipidaemic and antiplatelet agents”, Expert Opin. Ther. Patents, 11(8):1301-1327 (2001).
Colagiuri et al. American Journal of Public Health, 96(9):1562-1569 (2006).
Curtis et al., The Journal of the American Board of Family Practice, 18:37-43 (2005).
Epple et al. Bioorganic & Medicinal Chemistry Letters, 16:4376-4380 (2006).
Everett et al., “The role of hepatic peroxisome proliferator-activated receptors (PPARs) in health and disease,” Liver, 20:191-199 (2000).
Fruchart, “PPAR and Cardiovascular Risk: Overview,” J. Cardiovasc. Risk, 8(4):185-186 (2001).
Golub et al., Science, 286:531-537 (1999).
Gross et al., Best Practice & Research Clinical Endocrinology & Metabolism, 21:687-710 (2007).
Havranek et al., “E/Z Isomerization of 3,3-disubstituted allylic thioethers” Tetrahedron Lett., vol. 48, pp. 6970-6973 (2007).
Hussain et al., Diabetes Research and Clinical Practice, 76:317-326 (2007).
International Preliminary Report on Patentability and Written Opinion for Application No. PCT/EP2005/052013, mailed Nov. 7, 2006.
International Search Report and Written Opinion of the ISR, PCT/EP2005/052013 dated Nov. 16, 2006.
Jones, “Peroxisome Proliferative-Activated Receptor (PPAR) Modulators: Diabetes and Beyond,” Medicinal Research Reviews, 21(6):540-552 (2001).
Kaplan et al., “PPARs, Insulin Resistance and Type 2 Diabetes,” J. Cardiovasc. Risk, vol. 8(4), pp. 211-217 (Aug. 2001)
Kersten et al., “Roles of PPARs in health and disease,” Nature, vol. 405, pp. 421-424 (May 2000).
Landreth et al., Neurobiology of Aging, 22:937-944 (2001).
Lee et al., “PPAR-delta regulates glucose metabolism and insulin sensitivity”, Proceedings of the National Academy of Sciences of the USA, 103(9):3444-3449 (2006).
Liu et al., “Identification of a Series of PPAR gamma/delta Dual Agonists via Solid-Phase Parallel.Synthesis,” Bioorg. Med. Chem. Lett., 11:2959-2962 (2001).
Michalik et al., “Peroxisome proliferator-activated receptors: three isotypes for a multitude of functions,” Curr. Opin. Biotechnology, 10:564-570 (1999).
Miller et al., “Novel peroxisome proliferator-activated receptor ligands for type 2 diabetes and the metabolic syndrome,
Dailey Robert S.
High Point Pharmaceuticals, LLC
Rollins Samuel B.
Zucker Paul A
LandOfFree
Compounds, their preparation and use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds, their preparation and use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds, their preparation and use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4301609